Cutaneous leukocytoclastic vasculitis associated with letrozole.
| Data(s) |
2014
|
|---|---|
| Resumo |
Aromatase inhibitors are increasingly used in the treatment of early and metastatic breast cancer. They can produce various skin adverse effects but are only rarely associated with cutaneous vasculitis. We report the first case of cutaneous vasculitis clearly associated with the use of aromatase inhibitor letrozole. |
| Identificador |
http://serval.unil.ch/?id=serval:BIB_EAFEDE77DFF7 isbn:1477-092X (Electronic) pmid:23676512 doi:10.1177/1078155213480535 |
| Idioma(s) |
en |
| Fonte |
Journal of Oncology Pharmacy Practice, vol. 20, no. 2, pp. 146-148 |
| Palavras-Chave | #Aged; Antineoplastic Agents/adverse effects; Antineoplastic Agents/therapeutic use; Aromatase Inhibitors/adverse effects; Aromatase Inhibitors/therapeutic use; Breast Neoplasms/drug therapy; Female; Humans; Nitriles/adverse effects; Nitriles/therapeutic use; Triazoles/adverse effects; Triazoles/therapeutic use; Vasculitis, Leukocytoclastic, Cutaneous/chemically induced |
| Tipo |
info:eu-repo/semantics/article article |
